
AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

